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Abstract: Proteolytic enzymes (also termed peptidases, proteases and proteinases) are 
capable of hydrolyzing peptide bonds in proteins. They can be found in all living 
organisms, from viruses to animals and humans. Proteolytic enzymes have great medical 
and pharmaceutical importance due to their key role in biological processes and in the  
life-cycle of many pathogens. Proteases are extensively applied enzymes in several sectors 
of industry and biotechnology, furthermore, numerous research applications require their 
use, including production of Klenow fragments, peptide synthesis, digestion of unwanted 
proteins during nucleic acid purification, cell culturing and tissue dissociation, preparation 
of recombinant antibody fragments for research, diagnostics and therapy, exploration of the 
structure-function relationships by structural studies, removal of affinity tags from fusion 
proteins in recombinant protein techniques, peptide sequencing and proteolytic digestion of 
proteins in proteomics. The aim of this paper is to review the molecular biological aspects 
of proteolytic enzymes and summarize their applications in the life sciences. 
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1. Scope of the Review 
Proteolytic enzymes are capable of hydrolyzing peptide bonds and are also referred to as peptidases, 
proteases or proteinases [1]. 
The physiological function of proteases is necessary for all living organisms, from viruses to 
humans, and proteolytic enzymes can be classified based on their origin: microbial (bacterial, fungal 
and viral), plant, animal and human enzymes can be distinguished. 
Proteolytic enzymes belong to the hydrolase class of enzymes (EC 3) and are grouped into the 
subclass of the peptide hydrolases or peptidases (EC 3.4). Depending on the site of enzyme action the 
proteases can also be subdivided into exopeptidases or endopeptidases. Exopeptidases catalyze the 
hydrolysis of the peptide bonds near the N- or C-terminal ends of the substrate. Aminopeptidases 
(Figure 1) can liberate single amino acids (EC 3.4.11), dipeptides (dipeptidyl peptidases, EC 3.4.14) or 
tripeptides (tripeptidyl peptidases EC 3.4.14) from the N-terminal end of their substrates. Single amino 
acids can be released from dipeptide substrates by dipeptidases (EC 3.4.13) or from polypeptides by 
carboxypeptidases (EC 3.4.16-3.4.18) (Figure 1), while peptidyl dipeptidases (EC 3.4.15) liberate 
dipeptides from the C-terminal end of a polypeptide chain. Endopeptidases (Figure 1) cleave peptide 
bonds within and distant from the ends of a polypeptide chain [2]. 
Figure 1. Action of aminopeptidases and carboxypeptidases removing the terminal amino 
acid residues as well as endopeptidases on a polypeptide substrate (having n residues). Red 
arrows show the peptide bonds to be cleaved. 
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Based on the catalytic mechanism and the presence of amino acid residue(s) at the active site the 
proteases can be grouped as aspartic proteases, cysteine proteases, glutamic proteases, metalloproteases, 
asparagine proteases, serine proteases, threonine proteases, and proteases with mixed or unknown 
catalytic mechanism [3]. 
The current classification system further classifies the proteases into families based on sequence 
similarities, furthermore, homologous families are grouped into clans using a structure-based 
classification [3,4]. Classification and nomenclature of proteolytic enzymes as well as a detailed 
description of individual proteases is available in the MEROPS database [3]. 
Action of the proteolytic enzymes is essential in several physiological processes, e.g., in digestion 
of food proteins, protein turnover, cell division, blood-clotting cascade, signal transduction, processing 
of polypeptide hormones, apoptosis and the life-cycle of several disease-causing organisms including 
the replication of retroviruses [5,6]. Due to their key role in the life-cycle of many hosts and pathogens 
they have great medical, pharmaceutical, and academic importance [7–9]. 
It was estimated previously that about 2% of the human genes encode proteolytic enzymes [8] and 
due to their necessity in many biological processes proteases have become important therapeutic 
targets [8]. They are intensively studied to explore their structure-function relationships, to investigate 
their interactions with the substrates and inhibitors, to develop therapeutic agents for antiviral therapies [9] 
or to improve their thermostability, efficiency and to change their specificity by protein engineering for 
industrial or therapeutic purposes [7]. Studying proteolytic enzymes is highly justified by their key role 
in several fields of industry [2,10–12], as well. The worldwide market of industrial enzymes was 
estimated to reach $3.3 billion value in 2010 and the largest segment of this market is related to 
proteases [13]. 
Proteases are extensively applied enzymes in several sectors of industry and biotechnology, 
furthermore, numerous research applications require the use of them, including the production of 
Klenow fragments, peptide synthesis, digestion of unwanted proteins during nucleic acid purification, 
use of proteases in cell culture experiments and in tissue dissociation, preparation of recombinant 
antibody fragments for research, diagnostics and therapy, exploration of the structure-function 
relationships by structural studies, removal of affinity tags from fusion proteins in recombinant protein 
techniques, peptide sequencing, and proteolytic digestion of proteins in proteomics. 
This review focuses on the application of proteolytic enzymes in life sciences, especially in the field 
of molecular biology. The summary table of proteases discussed in this review (Table 1) contains the 
substrate specificities of the enzymes which are grouped based on their catalytic mechanisms. 
2. Molecular Biology Research Applications 
2.1. Klenow Fragment Production 
The Klenow fragment is the large fragment of the E. coli DNA polymerase I enzyme. While the 
holoenzyme has 5'→3' polymerase, 3'→5' and 5'→3' exonuclease activities, the Klenow fragment has 
only the polymerase and the 3'→5' exonuclease activities. The Klenow fragment has several 
applications in the recombinant DNA technology, including the labeling, sequencing, and site-specific 
mutagenesis of DNA. 
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Table 1. Substrate specificity of some proteolytic enzymes used in molecular biology 
research. Proteases are classified based on their catalytic mechanisms, furthermore, the main 
sources and enzyme specificities are indicated. The arrows indicate the sites of cleavages. 
Enzyme Main source Cleavage site 
Endopeptidases   
Serine proteases  
 
Trypsin bovine -Arg or Lys↓nonspecific- 
Chymotrypsin bovine -Trp (or Phe, Leu, Tyr)↓nonspecific- 
Enterokinase bovine Asp-Asp-Asp-Lys↓nonspecific- 
Endoproteinase Arg-C microbial -Arg↓nonspecific- 
Endoproteinase Glu-C microbial -Glu (or Asp)↓nonspecific- 
Endoproteinase Lys-C microbial -Lys↓nonspecific- 
Elastase porcine -Ala (or Gly or Val)↓nonspecific- 
Subtilisin microbial -Trp (or Tyr, Phe, Leu)↓nonspecific- 
Proteinase K fungal -aromatic, aliphatic or hydrophobic ↓nonspecific- 
Thrombin bovine 
-Arg (or Lys)↓nonspecific- 
specific for -Leu-Val-Pro-Arg-↓Gly-Ser- 
Factor Xa bovine 
-Arg (or Lys)↓nonspecific- 
specific for -Leu-Val-Pro-Arg-↓Gly-Ser- 
WNV protease E. coli -Lys (or Arg)-Arg↓Gly-Ser- 
Cysteine proteases  
 
Bromelain plant -nonspecific↓nonspecific- 
Papain plant -Arg (or Lys)↓nonspecific- 
Ficin (ficain) plant -nonspecific↓nonspecific- 
Rhinovirus 3C E. coli 
Gly-Pro dipeptide after the scissile bond 
highly specific for -Leu-Glu-Val-Leu-Phe-Gln↓Gly-Pro- 
TEV protease E. coli specific for -Gln-Asn-Leu-Tyr-Phe-Gln↓Gly- 
TVMV protease E. coli specific for -Glu-Thr-Val-Arg-Phe-Gln↓Ser- 
Metalloproteases  
 
Endoproteinase Asp-N microbial -nonspecific↓Asp- 
Thermolysin microbial -Leu (or Phe)↓Leu (or Phe, Val, Met, Ala, Ile)- 
Collagenase microbial -Pro-neutral↓Gly-Pro- 
Dispase microbial -nonspecific↓non-polar- 
Aspartic proteases  
 
Pepsin porcine -Phe (or Tyr, Leu, Trp)↓Trp (or Phe, Tyr, Leu)- 
Cathepsin D bovine -Phe (or Leu)↓nonspecific (not Val, Ala)- 
Exopeptidases   
Serine proteases   
Carboxypeptidase Y yeast -nonspecific↓nonspecific 
Cysteine proteases   
Cathepsin C bovine removes N-terminal dipeptide 
DAPase porcine removes N-terminal dipeptide 
Metalloproteases   
Carboxypeptidase A bovine -nonspecific↓aromatic or branched preferred 
Carboxypeptidase B porcine specific for C-terminal Arg or Lys 
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The enzymatic method to release the large protein fragment from the DNA polymerase I holoenzyme 
by proteolysis was published in 1970 [14]. Subtilisin-catalyzed proteolytic cleavage was used to 
produce Klenow fragment leading to the retention of the polymerase and the 3'→5' exonuclease 
activities and to the loss of 5'→3' exonuclease activity of the intact polymerase [6]. 
Nowadays, commercially available Klenow fragment is produced in recombinant ways in E. coli 
strains which carry the gene of large fragment of DNA polymerase I, therefore, the proteolytic 
production of Klenow fragment has mainly historical significance. 
2.2. Enzymatic Peptide Synthesis 
While enzymatic peptide synthesis has been frequently used to synthesize peptides for pharmaceutical 
and nutritional purposes (Table 2), this method is also essential for several research applications. The 
enzymatic method has several advantages compared to chemical methods, such as stereo specificity with 
side-chain protection, and the non-toxic nature of solvents coupled with the possibility of recycling the 
reagents used for synthesis. Enzymes have been selected considering their specificity for amino acid 
residues (Table 2), but this type of application is limited by the possibility of the hydrolysis of the 
peptide bond. The types of the enzymatic synthesis and its requirements have been reviewed [15–17]. 
Enzymatic peptide synthesis can be made by equilibrium- or kinetically-controlled methods.  
Table 2. Examples of peptides synthesized by proteases. 
Peptide Sequence Enzyme(s) Reference 
Aspartame Asp-Phe Thermolysin [18] 

















mouse EGF (21–31) 
His-Ile-Glu-Ser-Leu-Asp-
SerTyr-Thr-Cys 
Papain, trypsin [22] 
2.2.1. Kinetically Controlled Peptide Synthesis 
The scheme for chymotrypsin-catalyzed kinetically-controlled Z-D-Leu-L-Leu-NH2 synthesis [23] is 
illustrated in Figure 2. The acyl donor Z-D-Leu that is activated by carbamoylmethyl (Cam) ester and 
chymotrypsin (E) form the enzyme-substrate complex first and after that the covalently linked Z-D-
Leu-E intermediate with the loss of the carbamoylmethyl ester. If this intermediate is attacked by 
water, hydrolysis occurs, which results in the Z-D-Leu-OH fragment. However if a more powerful 
nucleophile (e.g., alcohol or thiol) is present in the media, the enzyme produces a peptide bond instead 
of the cleavage [15] and the Z-D-Leu-L-Leu-NH2 dipeptide may be formed in the presence of H-L-Leu-NH2 
nucleophile (Figure 2). The product yield depends on the kinetics of the two nucleophilic reactions, 
however, the reaction is faster and requires lower substrate enzyme ratios compared to the equilibrium-
controlled synthesis, due to the activated acyl donor.  
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Figure 2. Kinetically-controlled synthesis of Z-D-Leu-L-Leu-NH2 dipeptide. After the 
formation of enzyme-substrate complex (K1) a covalent enzyme-substrate intermediate is 
formed (K2). The intermediate is subjected to the attack from H2O or other nucleophiles 
(Nu). KH is the equilibrium constant of hydrolysis, KT is the equilibrium constant of the 
transferase reaction. 
 
The acyl donor activating agent must not only be an ester, but an amide or a nitrile as well. Only 
serine or cysteine proteases can be used to perform the kinetically controlled peptide synthesis, as these 
enzymes can act as transferase and hence are able to catalyze the transfer of an acyl group from the acyl 
donor to the nucleophile through the formation of a covalent acyl enzyme intermediate. Papain, 
thermolysin, trypsin and α-chymotrypsin are mostly used for kinetically-controlled peptide synthesis [24]. 
The yield of peptide product will depend on the apparent ratio of transferase to hydrolase rate constants 
(KT/KH)app and the rate at which the peptide product is hydrolyzed. The (KT/KH)app values of proteases 
used for kinetically-controlled synthesis are in the range of 10
2–104 [17]. 
2.2.2. Equilibrium-Controlled Synthesis 
In the case of the equilibrium-controlled synthesis the process is the reverse of hydrolysis. 
Important problems of this enzymatic method of peptide synthesis are the low reaction rates and the 
need of increased yield because proteases do not alter the equilibrium of the reaction. A high amount 
of the enzyme is often required together with the precise reaction conditions to drive the equilibrium 
towards synthesis [15]. A higher rate of peptide bond formation can be reached by the appropriate pH 
of the reaction medium (changing the equilibrium of ionization) but there are several other ways to 
increase the yield of the reaction: 
(a) Precipitation of the product is the classical method. When certain soluble carboxyl amine 
components are used as reactants the products will precipitate and the reduced concentration of soluble 
products will drive the equilibrium towards synthesis. In this case the yield of the product depends on 
the concentration of the starting materials and can be determined by the solubility of the product [17]. 
(b) In a biphasic system the enzyme acts in an aqueous environment that is surrounded by a water 
immiscible medium; the water content of the system is around 2–5%. The reactants (dissolved in high 
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concentrations) can diffuse from the organic phase into the water until the equilibrium is reached; the 
enzyme-catalyzed synthesis is followed by the diffusion of the products back into the organic phase. The 
organic phase reduces the dielectric constant of the medium and thus the acidity of the carboxyl group of 
the acyl donor as well, which in turn promotes the synthesis of the peptide bond instead of hydrolysis [24]. 
This method is applicable only for the synthesis of water insoluble products. 
(c) The dissolved state system can be used for the synthesis of water-soluble products (short 
peptides, high molecular weight peptides and proteins). In this environment forcing the reaction 
towards peptide synthesis requires the mass action, the addition of a water-miscible organic co-solvent 
in high concentration or the excess of one reactant. In serine protease-catalyzed reaction in water, the 
rate determining feature is the acylation of the enzyme while the product yield at equilibrium depends 
on the partition coefficient and the ratio of the aqueous and organic volumes [17]. The chymotrypsin- 
and subtilisin-catalyzed synthesis of N-Bz-L-Tyr-L-Leu-NH2 is more efficient in hydrophobic organic 
solvents; adding water in sub-saturating concentration increases the yield of the chymotrypsin-
catalyzed peptide synthesis [25]. 
2.2.3. Strategies Used in Enzymatic Synthesis 
The use of enzymes in organic solvents have several advantages compared to aqueous solvents 
which have led to their widespread application: the thermodynamic equilibrium can be shifted towards 
synthesis, the undesirable side reactions can be reduced, the nonpolar substrates are more soluble in 
organic solvents, the separation process and enzyme recovery is more effective in a low water-containing 
environment [26–29]. Many proteases, such as thermolysin, subtilisin and α-chymotrypsin [26,29] can 
maintain their active conformation in organic solvents and show good functionality in the synthesis of 
aspartame and demorphin derivatives. 
However, the use of enzymes in organic solvent has also disadvantages such as the unfavorable 
effects of the organic solvents on enzyme activity and stability. The modification of biocatalysts by 
protein engineering [30,31] and/or chemical modification or the use of naturally solvent-tolerant 
proteases [32] for peptide synthesis is a developing field. The driving force of this field is the aim of 
making biocatalysts with proper features to suit them for the reactions under specific synthesis 
conditions. Site-directed mutagenesis is a very effective tool and can be used by protein engineers to 
screen mutants with enhanced stability, activity or specificity, furthermore, this method can be used to 
explore structure-function relationships (rational design). 
Subtilisin has been extensively studied and engineered via site-directed mutagenesis to make it 
more capable of peptide bond formation in aqueous solution [33]. Single and multiple mutations have 
been introduced into subtilisin to increase its stability and make it more resistant against oxidizing 
agents, thermal denaturations and inactivation effects of polar solvents [28]. 
Thermolysin has a higher synthesis rate compared to the solvent stable PST-01 protease from 
Pseudomonas aeruginosa. Considering the high structural similarity of these enzymes, the synthetic 
activity of PST-01 protease was increased by the Y114F mutation [31], moreover, the Y114R and 
Y114S mutations resulted in better activity enhancement. 
Chemical modification is also an efficient method to modify the properties of enzymes used for 
peptide synthesis. Thiol-subtilisin, in which the serine residue has been chemically changed to cysteine 
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at the active site, shows an enhanced aminolysis to hydrolysis ratio in aqueous solution and in dimethyl 
sulphoxide. The stability of proteases can also be increased by chemical modification e.g., a hydrophilic 
carbohydrate-polyacrylate polymer coat can make the enzymes highly active and stable in polar 
solvents and more resistant against thermal inactivation [28]. 
Immobilization of proteases is the most frequently applied method for the recovery of products 
without great loss of the catalysts, which greatly decreases the cost of the synthesis. This approach also 
ensures better operational stability of biocatalysts and control of the reaction. Enzyme immobilization 
techniques can be divided into five groups: (a) covalent attachment to solid support; (b) absorption on 
solid support; (c) entrapment in polymeric gel; (d) crosslinking with bifunctional reagents and (e) 
encapsulation [17,34]. 
Substrate engineering means the manipulation of the leaving group and is a powerful tool to 
increase the specificity of the proper enzyme and/or increase the rate and the yield of the reaction [24]. 
Protease-catalyzed synthesis of stereochemically modified peptides is also a preferable application 
compared to chemical synthesis due to stereospecificity of the proteases. 
Proteases can bind not only natural substrates, but also specifically designed substrate mimetics, 
which are also very useful tools to increase the yield of peptide synthesis. Substrate mimetics can bind 
to the active site of the enzyme and in this way proteases can be used for the synthesis of products 
containing non-specific amino acids. The undesired cleavage of the newly synthesized peptide bonds 
can be avoided using this method and it is not required to change the properties of the medium or the 
enzyme [17]. 
The production of peptides with amides at their C-termini is a great challenge for enzymatic peptide 
synthesis, but amidation may be required to retain biological activity. 
2.3. Nucleic Acid Isolation 
Generally, the first step of nucleic acid isolation protocols is the lysis of the biological material 
containing the DNA or RNA of interest. Before the purification and concentration of nucleic acids the 
contaminating proteins and other macromolecules have to be removed from the sample. Undamaged 
nucleic acids can be isolated when the degradation of the DNA and RNA present in the sample is 
avoided by the inhibition and removal of DNases and RNases. The nucleases can be inhibited by the 
addition of chelators (e.g., EDTA) which bind the ions essential for their action. Besides the 
inactivation of nucleases, proteolytic enzymes are applied during the nucleic acid isolation to remove 
total protein content of the sample. 
The most widely used proteolytic enzyme in nucleic acid purification is the Proteinase K, which 
was described in 1974 [35]. Proteinase K is a non-specific serine endopeptidase which can catalyze the 
cleavage of peptide bonds at the carboxylic side of aromatic, aliphatic, or hydrophobic amino acid 
residues. Besides the digestion of unwanted proteins, Proteinase K also quickly inactivates the 
nucleases which might degrade the nucleic acids present in the sample [36]. This proteolytic digestion 
decreases the level of contaminants in the nucleic acid extract and prevents nucleic acids from 
degradation leading to a higher yield of the DNA or RNA to be isolated. 
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2.4. Cell Isolation and Tissue Dissociation 
Cell biology studies frequently require the dissociation of primary tissues and the isolation of viable 
cells for tissue culturing. The most common method for cell isolation is the enzymatic digestion of the 
junctions connecting the cells and the components of the surrounding extracellular matrix, by which 
the cells can be released from a wide variety of tissues. Several enzymes are available in the market for 
the detachment of cultured cells, cell dissociation and cell component or membrane-associated protein 
isolation [37,38]. Besides the polysaccharidases, nucleases and lipases, the proteases are the most 
important enzymes used widely to dissociate cells from tissues. 
The experimental conditions of cell isolation are functions of several parameters, including the type 
of the tissue and the source of its origin. Cells with high viability can be isolated in high yield using a 
suitable enzyme or the optimal combination of enzymes. As proteases differ in their specificities, 
different enzymes are recommended to be used use for most effective tissue disruption, depending on 
the origin and type of the tissue. We describe below the enzymes most commonly used for cell isolation. 
The matrix metalloproteinase collagenase was first isolated in 1953 [39]. This endopeptidase can 
digest the collagenous extracellular matrix in a zinc-dependent manner. Collagenase cleaves the peptide 
bonds within the triple helices of native collagen, between a neutral amino acid and Gly within the  
Pro-X-Gly-Pro sequence. This sequence can be found most frequently in the collagen; therefore collagenases 
digest other proteins less efficiently. A commercially available collagenase (clostridiopeptidase A) is 
produced by Clostridium histolyticum, and it is capable of digesting collagen fibers very effectively. 
Solutions supplied for tissue dissociation contain collagenase and other additional proteinases which 
can digest the components of the extracellular matrix [38,40]. The serine protease elastase is a unique 
enzyme which can cleave the peptide bonds in elastin, therefore, it is generally used to dissociate 
tissues containing a high amount of elastin connective fibers. Elastase cleaves peptide bonds next to 
smaller neutral amino acids and besides its protease activity it also has esterase and amidase activities. 
Papain is a cysteine peptidase of Carica papaya latex. Papain, similarly to elastase, also has amidase 
and esterase activities and has a broad specificity. Papain has less damaging effects on tissues and 
therefore it is typically applied for cell dissociation of neuronal tissues. Besides cell dissociation, 
papain is also widely used for integral membrane protein solubilization and for digestion of 
proteoglycans. The serine protease trypsin is a very specific proteinase cleaving the peptide bonds at 
the C-terminal end of positively charged Lys and Arg side chains. Due to the high specificity of trypsin 
the digestion of tissue proteins is less effective and it is generally used for tissue dissociation together 
with other proteolytic enzymes. Serine protease chymotrypsin cleaves peptide bonds preferentially at 
the carboxyl side of aromatic Tyr, Trp and Phe residues. Chymotrypsin is less widely used for tissue 
dissociation; the use of other additional proteases is required for efficient digestion. The Zn-
metalloprotease dispase is also a neutral protease. This non-specific protease cleaves the peptide bonds 
of proteins at the amino side of non-polar amino acid residues.  
2.5. Cell Culturing 
Cells isolated from a tissue can be cultured separately from the organism in cell culture flasks using 
appropriate growth medium. Adherent cells grown in a cell culture flask are attached to the surface by 
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protein bridges which have to be disrupted during passaging. The cells can be released from the cell 
flask surface mechanically using a cell scraper or can be detached by a protease treatment using 
trypsin solution. 
Trypsinization means the process used for the detachment of adherent cells using trypsin solution to 
digest the adhesion molecules by which the cells are attached to the surface of the culture flask. 
Trypsin solutions generally contain EDTA to reduce the concentration of metal ions that might 
inhibit trypsin. 
Although trypsinization is the most commonly used method to detach adherent cells from cell 
culture flasks, the effects of this protease treatment were only recently studied in detail. It was found 
that trypsinization can affect the extracellular matrix surrounding the cells [41] and has physiological 
effects on cells grown in cell cultures [42]. Trypsin treatment can lead to cleavage of membrane 
proteins and receptors, which can cause significant changes in the expression level of different 
proteins: level of growth- and metabolism-related protein expressions were found to be  
down-regulated after trypsinization, while up-regulation of apoptosis-related protein expressions was 
seen after the protease treatment [42,43]. This effect should be taken into account when trypsinization 
is involved in experimental design. 
2.6. Antibody Fragment Production 
Antibody molecules are produced by the immune system against foreign substances and are 
classified into the immunoglobulin superfamily of the proteins (Figure 3A). They consist of four 
polypeptide chains, two identical heavy chains (H) and two identical light chains (L) which are 
connected by disulfide bridges. Both the H and the L chains contain variable (VH and VL) and constant 
(CH1, CH2, CH3 and CL) regions, respectively. The VH and VL chains, containing hypervariable 
regions, are responsible for the antigen-antibody interactions and determine the antigen specificity [6]. 
Fragments of the monoclonal antibodies are widely used in diagnostics, therapeutics and in 
biopharmaceutical research [44–46] having beneficial properties compared to the whole immunoglobulin 
molecules due to their smaller size and lower immunogenicity [44]. Fragments of whole 
immunoglobulin molecules can be produced using recombinant DNA technology or can be generated by 
enzymatic digestion. Here we discuss the proteolytic antibody fragmentation method. 
Generally, the papain, pepsin and ficin proteases are used for the specific digestion of IgG 
molecules. Digestion of an antibody by the cysteine protease papain results in three fragments due to 
the cleavage of peptide bonds in the hinge region between CH1 and CH2 domains: one Fc 
(crystallizable) and two identical Fab (antigen binding) fragments are released (Figure 3B). While both 
released Fab fragments carry one antigen-binding site, the Fc fragment does not have antigen-binding 
ability. The aspartic acid protease pepsin cleaves the peptide bonds of the antibody near the disulfide 
bonds connecting the H chains (Figure 3C). This digestion results in the release of the peptides of the 
Fc region and one F(ab')2 fragment containing both antigen binding sites. The cysteine protease ficin 
can release both F(ab')2 or Fab fragments (Figure 3D), depending on the cysteine concentration [44]. 
 
 
Biomolecules 2013, 3 933 
 
 
Figure 3. Structure of IgG antibody molecules (A) and fragments released after proteolytic 
digestion using papain (B), pepsin (C) or ficin (D). 
 
The in vivo applications of the large, pentameric IgM immunoglobulines could be restricted because 
of their large size. Proteolytic fragmentation of IgM moleucles is also a useful method to produce 
smaller, active Fab, Fab', F(ab')2 or ―IgG-like‖ fragments which have beneficial properties compared to 
the whole IgM molecules. Trypsin and pepsin are useful enzymes for IgM fragmentation, pepsin can 
generate Fab and F(ab')2 fragments, while trypsin can generate ―IgG-like‖ fragments, as well. Papain 
cannot be used for IgM fragmentation because of the production of heterogeneous fragments.  
Digestion of monoclonal antibodies by papain or pepsin is still used to produce Fab or F(ab')2 
fragments [44]. There are several products available on the market obtained by proteolytic cleavage of 
antibodies, furthermore, several companies supply fragmentation kits for antibody fragment 
preparation. In some cases it could be preferable to produce the Fab fragments in high quality by 
recombinant expression in cell lines and obtain the fragment in sufficient quantity. For example,  
the Fab fragments produced by recombinant expression were found to be more preferable for the 
crystallization experiments because of the higher quality of the protein sample [47]. 
Antibody fragments have several beneficial properties for in vivo applications compared to whole 
antibody molecules. Due to their smaller size they have higher mobility and can penetrate tissues or 
permeate cell membranes more easily. As antigen-binding fragments lack the Fc fragments, they have 
lower immunogenicity, as they contain only their antigen-binding domain sites (Fab, Fab'  
or F(ab')2 fragments) and do not carry the regions responsible for antibody effector functions, 
furthermore, they do not form large immunocomplexes. 
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The antigen-binding fragments of antibodies have great importance from the viewpoint of clinical 
and therapeutic applications. Antibody fragments could be administered to prevent the development of 
a disease (e.g., restenosis), could be applied during the diagnosis (e.g., metastatic breast and colon 
cancer) or for the treatment of some diseases (e.g., macular degeneration) or to detect toxins or 
neutralize snake venoms [44,45]. The current number of antibody-based therapeutics approved by the 
FDA is 35, while several other antibodies are in clinical trials. The relevance of antibody fragments in 
structural studies is discussed in detail in the following paragraph. Further important biotechnological 
applications of antibody fragments, e.g., as immunodetection, immunopurification and detoxification, 
have been reviewed in the recent past [46]. 
2.7. Structural Studies 
Crystallographers have great challenges in the structure determination of transmembrane proteins. It 
is difficult to crystallize these proteins due to their high molecular flexibility, hydrophobic surfaces and 
low solubility. Antibody fragments are very useful tools for solving these problems. Specific binding 
of antibody fragments can increase the overall hydrophilicity of proteins and the solubility of the 
transmembrane proteins, furthermore, they can decrease the flexibility and stabilize the conformation 
of the molecule [48]. The structures of the membrane proteins co-crystallized with antibody fragments 
can be determined at higher resolution because these crystals have a higher diffraction quality [49–51]. 
The proteases have great indirect significance in structure determination, because the antibody 
fragments produced by proteolytic cleavage of whole immunoglobulins can be used to improve the 
crystallization properties [52–54]. 
The proteases are not only tools for crystallographers but are also important target molecules for 
structural biologists and have great relevance in antiviral therapies, drug and therapeutics development 
from the viewpoint of structural biology. Besides interest in proteases with unknown structure, the 
results of structural studies can help researchers evaluate the structure-function relationships more 
efficiently; increasing knowledge on the structural organization of viral proteases can help to explore 
their action, perform comparative studies by which we can better understand the structure-function and 
evolutionary relationships and recognize general or specific features [55–57]. One of the main driving 
forces of structure determination of proteases is the need for the development of efficient drugs for 
antiviral therapies [7,9,58–60]. Both structural and enzymatic inhibition studies are required for the 
structure-based drug development of protease inhibitors [61]. Structural data can also help protein 
engineers to alter the specificity and to improve the enzymatic properties of proteases by structure-
guided mutagenesis [62–64] for several purposes. 
2.8. Fusion Tag Removal 
The proteins produced by recombinant techniques are typically linked with a fusion partner termed 
a fusion tag. The introduction of a fusion tag means the fusion of an additional protein or peptide to the 
recombinant protein. These fusion tags are extensively used from basic research to high-throughput 
structural biology owing to the several advantages they provide in the expression of different 
recombinant proteins [65,66]. The tags largely aid the detection and purification of proteins; moreover 
they also could have a favorable effect on protein yield and/or solubility. Tags can prevent proteins 
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from proteolytic digestion, can protect antigenicity or facilitate the folding of the fusion protein.  
On the other hand, they can also negatively alter solubility, structural integrity and biological  
activity [47,67,68] or may cause a disadvantage for further application of the protein, so the removal of 
a tag can be crucial [66]. 
Commonly used affinity tags and fusion protein partners are the hexahistidine-tag (His6),  
FLAG-tag, maltose binding protein (MBP), glutathione S-transferase (GST), thioredoxin (TRX), small 
ubiquitin-like modifier (SUMO), ubiquitin (Ub) and green fluorescent protein (GFP) [69]. 
In some cases the tag can be removed by a chemical treatment but those methods are rather 
unspecific compared to enzymatic cleavages and may lead to protein denaturation and/or side chain 
modifications of amino acids in the target protein. The specificity and detergent sensitivity of common 
proteases used for tag removal have been examined and reviewed previously [70–73]. Both endo- and 
exo-proteases could be suitable for fusion tag removal. 
2.8.1. Endoproteases 
Serine proteases such as enterokinase (also referred to as enteropeptidase), factor Xa and thrombin 
have been widely used for many years to remove N-terminal tags, but several cases have been reported 
in which they cleaved not only at the desired cleavage site but also in the protein of interest. These 
incidents led to the extensive application of viral proteases like human rhinovirus (HRV) 3C protease 
and tobacco etch virus (TEV) protease. While sequences recognized by a cellular serine protease and 
the viral proteases could be similar, the viral proteases cleave the protein substrates at the undesired 
sites less efficiently due to their high specificity and low catalytic rate, moreover, recombinant viral 
proteases can be produced in high quantities in E. coli [73]. These findings and the limited activity of 
the generally used serine proteases in some detergents, which are needed to study the membrane 
proteins, inspired the search for other viral proteases for tag removal, such as Tobacco Vein Mottling 
Virus (TVMV) protease [74], West Nile Virus (WNV) protease [75] and some alphaviral proteases: 
Venezuelan Equine Encephalitis Virus (VEEV) protease, Semliki Forest Virus (SFV) and Sindbis 
Virus (SIN) protease [76]. 
2.8.2. Exopeptidases 
Aminopeptidases and carboxypeptidases are not as widely used as endopeptidases, as they 
frequently leave amino acid residues on the target protein, while it is easier to design cleavage sites 
with endopeptidases not to leave extra residues after the cleavage. However, if is still desired to add a 
tag onto the C-terminal of the target protein a carboxypeptidase may be used for its removal. Among 
metallocarboxypeptidases, type A carboxypeptidases remove mostly aromatic or branched aliphatic 
side chain containing amino acids, while type B carboxypeptidases prefer basic amino acids. 
Carboxypeptidases can be utilized to remove a His6 tag from the C-terminal end of a protein [77]. 
Dipeptidyl aminopeptidase (DAPase) is a useful enzyme for the removal of N-terminal dipeptides. 
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2.9. Proteomic Applications 
Proteomic studies are made with the aim to identify, characterize, and quantify the required samples 
and typically involve mass spectrometric (MS) analysis. Besides determination of the composition of 
protein complexes, chemical properties, post-translational modifications and structural properties of 
proteins can also be revealed by MS. 
MS is a powerful analytical method to measure the mass of proteins or peptides by the analysis of 
mass-to-charge ratio (m/z) ratio. Generally, the samples to be analyzed contain a mixture of various 
proteins and/or polypeptides that have to be separated and digested into smaller fragments before the MS 
analysis. Protein separation can be performed efficiently by polyacrylamide gel electrophoresis. The 
separated proteins can be digested after the electrophoresis by chemical cleavage or by enzyme-catalyzed 
digestion of peptide bonds. The process in which the bands or spots are cut out from the gel followed by 
the addition of protease(s) to the gel containing the protein(s) of interest is called in-gel digestion [78]. 
Proteolysis of whole proteins leads to the release of smaller peptides with different molecular masses 
which are suitable for MS analysis (Figure 4). 
Figure 4. Steps of proteomic analysis using mass-spectrometry after separation and in-gel 
digestion of proteins of interest. 
 
Trypsin is the most widely used proteolytic enzyme for protein digestion in MS analysis. Due to its 
high specificity it is easy to predict the cleavage sites and to compare the results of experimental 
enzymatic and theoretical in-silico digestion. The Asp-N, Lys-C, Arg-C and Glu-C enyzmes are also 
highly sequence-specific endoproteases but they are less active [78]. Chymotrypsin, pepsin, papain, 
elastase, subtilisin, proteinase K, thrombin, factor Xa and some other proteases are also suitable 
enzymes for fragmentation in MS analysis [79]. 
Several proteases are available for this fragmentation of which specificities are well established [79,80]. 
The number and length of released peptide fragments depends on the protease(s) applied for selective 
Biomolecules 2013, 3 937 
 
 
proteolysis of the targeted protein. Applications developed for in silico protein fragmentation are 
useful to predict the proteolytic fragments and to choose the most proper enzyme for the most effective 
digestion based on the enzyme specificities (http://prospector.ucsf.edu). 
Generally, highly sequence-specific proteases are preferred for protein fragmentation instead of less 
specific enzymes, as the latter ones produce a very complex mixture of fragments. In the case of the 
efficient fragmentation the peptide, the fragments have a proper length and are released in high yield, 
and the complete sequence of the whole protein can be covered by the analysis of the 
proteolytic fragments. 
3. Summary  
Besides extended application for nutritional and pharmaceutical purposes, proteases from natural 
sources are also widely used tools in molecular biology practice. Their degradative properties make 
them useful for general protein digestion in tissue dissociation, cell isolation, and cell culturing. The 
specificity and the predictability of cleavages by proteases enables their use for more specific tasks 
such as antibody fragment production, the removal of affinity tags from recombinant proteins and 
specific protein digestion in the proteomics field mainly for protein sequencing. Moreover, the already 
mentioned specificity makes proteases—in a water restricted environment—able to synthesize the 
peptide bonds instead of hydrolyzing them. This property combined with their enantioselectivity has 
also promoted their use in peptide synthesis. 
The expansion of knowledge has assisted the increase of applications of proteolytic enzymes for 
several purposes, and the application fields are widening with the help of protein engineering 
techniques and by chemical modification of the enzymes [7,62]. Studies made with the aim to better 
understand the structure and function of existing proteolytic enzymes and to obtain new, engineered 
proteases with altered properties for therapeutic, industrial or research fields require the use of the 
applications discussed in this paper. 
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